DOUBEK, Michael, Ivo PALÁSEK, Z. POSPÍŠIL, S. STRUNCOVÁ, Dana DVOŘÁKOVÁ, M. BORSKÝ, Martin KLABUSAY, Y. BRYCHTOVÁ, Marta KREJČÍ and Jiří MAYER. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNXa, CBFB, MLL gene translocations, or NPMI mutation. Frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression. Annals of Hematology. Springer, vol. 87, No 1, p. S4, 1 pp. ISSN 0939-5555. 2008.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Detection and treatment of molecular relapse in acute myeloid leukemia with RUNXa, CBFB, MLL gene translocations, or NPMI mutation. Frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
Name in Czech Detekce a léčba molekulárního relapsu při akutní myeloidní leukemii s genovými transkripty RUNXa, CBFB, MLL
Authors DOUBEK, Michael, Ivo PALÁSEK, Z. POSPÍŠIL, S. STRUNCOVÁ, Dana DVOŘÁKOVÁ, M. BORSKÝ, Martin KLABUSAY, Y. BRYCHTOVÁ, Marta KREJČÍ and Jiří MAYER.
Edition Annals of Hematology, Springer, 2008, 0939-5555.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.454
Organization unit Faculty of Medicine
UT WoS 000253375100010
Keywords (in Czech) Akutní lymfoblastická leukemie; fúzní transkript; prognostická hodnota
Keywords in English ACUTE LYMPHOBLASTIC-LEUKEMIA; FUSION TRANSCRIPTS; PROGNOSTIC VALUE
Tags ACUTE LYMPHOBLASTIC-LEUKEMIA, FUSION TRANSCRIPTS, PROGNOSTIC VALUE
Tags International impact
Changed by Changed by: prof. RNDr. Zdeněk Pospíšil, Dr., učo 707. Changed: 23/6/2009 13:37.
Abstract
Frequent quantitative monitoring of fusion transcripts is useful for reliably predicting hematological relapse in AML patients. Treatment for molecular relapse of AML can be successful.
Abstract (in Czech)
Častý kvantitativní monitoring fúzních transkriptů je užitečný pro věrohodnou predikci hematologického relapsů u pacientů s AML. Léčba molekulárního relapsu může být úspěšná.
Links
LC06024, research and development projectName: Centrum Jaroslava Hájka pro teoretickou a aplikovanou statistiku
Investor: Ministry of Education, Youth and Sports of the CR, Jaroslav Hájek Center for Theoretical and Applied Statistics
PrintDisplayed: 19/4/2024 10:32